{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:57:16Z","timestamp":1791853036208,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Castration-resistant prostate cancer (CRPC) constitutes an advanced stage of prostate cancer (PCa) that emerges following conventional androgen deprivation therapy (ADT). Docetaxel (DTX), a standard chemotherapeutic agent, is integral to the therapeutic regimen for CRPC. However, the development of resistance to DTX has significantly impeded its clinical efficacy. Histone lactylation and elevated lactate production are emerging as critical factors in cancer biology, yet their roles in CRPC and DTX resistance remain poorly understood. This study investigated the relationship between histone lactylation, lactate production, and DTX resistance in CRPC. Clinical analysis revealed significantly increased pan-lactylated protein (Pan Kla) expression in CRPC tissues compared to PCa, accompanied by elevated lactate production and lactate dehydrogenase (LDH) activity. Higher Pan Kla expression was linked to poor prognosis in CRPC. DTX-resistant CRPC (CRPC-R) samples exhibited significantly elevated Pan Kla and histone lactylation modifications, especially at H3K18la and H4K12la sites. Inhibition of lactate production using 2-deoxyglucose (2-DG) and oxamate reduced DTX resistance, suppressed cell migration, induced G0\/G1 phase arrest, and promoted autophagy. Moreover, CNN1 was identified as a potential downstream target of histone lactylation modifications in CRPC. Elevated CNN1 expression correlated with increased lactylation and DTX resistance, whereas its inhibition reversed the effects of lactate inhibition on cell cycle progression and autophagy. In vivo, CNN1 overexpression counteracted the tumor-suppressive effects of lactate inhibition, restoring tumor growth and autophagy levels. These findings suggested that histone lactylation and lactate metabolism, mediated by CNN1, play a crucial role in DTX resistance and tumor progression in CRPC, offering potential therapeutic targets for overcoming chemoresistance in CRPC.<\/jats:p>","DOI":"10.1038\/s41420-026-03141-8","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:08:10Z","timestamp":1778656090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Histone lactylation modification promotes docetaxel resistance and tumor progression through CNN1-Mediated autophagy and cell cycle arrest in Castration-resistant prostate cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Ruijie","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2743-1420","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"3141_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and Prevention of Prostate Cancer. Eur Urol Oncol. 2021;4:877\u201392.","journal-title":"Eur Urol Oncol"},{"key":"3141_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S16747","volume":"4","author":"MF Leitzmann","year":"2012","unstructured":"Leitzmann MF, Rohrmann S. Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clin Epidemiol. 2012;4:1\u201311.","journal-title":"Clin Epidemiol"},{"key":"3141_CR3","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules. 2022;27:5730.","journal-title":"Molecules"},{"key":"3141_CR4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/14728222.2023.2293757","volume":"27","author":"J Wang","year":"2023","unstructured":"Wang J, Ben-David R, Mehrazin R, Yang W, Tewari AK, Kyprianou N. Novel signatures of prostate cancer progression and therapeutic resistance. Expert Opin Ther Targets. 2023;27:1195\u2013206.","journal-title":"Expert Opin Ther Targets"},{"key":"3141_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/cancers13020327","volume":"13","author":"NJ Maitland","year":"2021","unstructured":"Maitland NJ. Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced? Cancers. 2021;13:327.","journal-title":"Cancers"},{"key":"3141_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1758834012449685","volume":"4","author":"C Hwang","year":"2012","unstructured":"Hwang C. Overcoming docetaxel resistance in prostate cancer: a perspective review. Ther Adv Med Oncol. 2012;4:329\u201340.","journal-title":"Ther Adv Med Oncol"},{"key":"3141_CR7","first-page":"726","volume":"3","author":"B Maristella","year":"2020","unstructured":"Maristella B, Consuelo B, Marcello T. Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways. Cancer Drug Resist. 2020;3:726\u201341.","journal-title":"Cancer Drug Resist"},{"key":"3141_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01462-0","volume":"22","author":"G Ambrosini","year":"2024","unstructured":"Ambrosini G, Cordani M, Zarrabi A, Alcon-Rodriguez S, Sainz RM, Velasco G, et al. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies. Cell Commun Signal. 2024;22:36.","journal-title":"Cell Commun Signal"},{"key":"3141_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41585-020-0298-8","volume":"17","author":"M Carceles-Cordon","year":"2020","unstructured":"Carceles-Cordon M, Kelly WK, Gomella L, Knudsen KE, Rodriguez-Bravo V, Domingo-Domenech J. Cellular rewiring in lethal prostate cancer: the architect of drug resistance. Nat Rev Urol. 2020;17:292\u2013307.","journal-title":"Nat Rev Urol"},{"key":"3141_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.37349\/etat.2024.00266","volume":"5","author":"N Thakur","year":"2024","unstructured":"Thakur N, Singh P, Bagri A, Srivastava S, Dwivedi V, Singh A, et al. Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies. Explor Target Antitumor Ther. 2024;5:1110\u201334.","journal-title":"Explor Target Antitumor Ther"},{"key":"3141_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01682-2","volume":"16","author":"Y Hu","year":"2024","unstructured":"Hu Y, He Z, Li Z, Wang Y, Wu N, Sun H, et al. Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenet. 2024;16:72.","journal-title":"Clin Epigenet"},{"key":"3141_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13478","volume":"56","author":"T Wang","year":"2023","unstructured":"Wang T, Ye Z, Li Z, Jing D-s, Fan G-x, Liu M-q, et al. Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. Cell Prolif. 2023;56:e13478.","journal-title":"Cell Prolif"},{"key":"3141_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Giannoni E, Chiarugi P. Lactate: A Metabolic Driver in the Tumour Landscape. Trends Biochem Sci. 2019;44:153\u201366.","journal-title":"Trends Biochem Sci"},{"key":"3141_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.190924","volume":"10","author":"K Shigeta","year":"2025","unstructured":"Shigeta K, Daimon T, Hongo H, Ku SY, Ozawa H, Haratake N, et al. MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy. JCI Insight. 2025;10:e190924.","journal-title":"JCI Insight"},{"key":"3141_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580617","volume":"10","author":"T Uo","year":"2020","unstructured":"Uo T, Sprenger CC, Plymate SR. Androgen receptor signaling and metabolic and cellular plasticity during progression to castration resistant prostate cancer. Front Oncol. 2020;10:580617.","journal-title":"Front Oncol"},{"key":"3141_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. Signal Transd Target Ther. 2022;7:305.","journal-title":"Signal Transd Target Ther"},{"key":"3141_CR17","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.ijbiomac.2022.10.014","volume":"222","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yang Z, Yu Y, Zhang P. HIF1\u03b1 lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. Int J Biol Macromol. 2022;222:2225\u201343.","journal-title":"Int J Biol Macromol"},{"key":"3141_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01856-1","volume":"22","author":"B Xie","year":"2023","unstructured":"Xie B, Lin J, Chen X, Zhou X, Zhang Y, Fan M, et al. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol Cancer. 2023;22:151.","journal-title":"Mol Cancer"},{"key":"3141_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20:114\u201330.","journal-title":"Autophagy"},{"key":"3141_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.gene.2016.02.040","volume":"585","author":"R Liu","year":"2016","unstructured":"Liu R, Jin JP. Calponin isoforms CNN1, CNN2 and CNN3: Regulators for actin cytoskeleton functions in smooth muscle and non-muscle cells. Gene. 2016;585:143\u201353.","journal-title":"Gene"},{"key":"3141_CR21","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3892\/etm.2021.10287","volume":"22","author":"W Liu","year":"2021","unstructured":"Liu W, Fu X, Li R. CNN1 regulates the DKK1\/Wnt\/\u03b2\u2011catenin\/c\u2011myc signaling pathway by activating TIMP2 to inhibit the invasion, migration and EMT of lung squamous cell carcinoma cells. Exp Ther Med. 2021;22:855.","journal-title":"Exp Ther Med"},{"key":"3141_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2024.100325","volume":"10","author":"R Sankar","year":"2024","unstructured":"Sankar R, John S, Devi P, Gupta S, Gupta S. Exploring the prognosis of calponin h1 in carcinogenesis: A novel target in biomedical research. Oral Oncol Rep. 2024;10:100325.","journal-title":"Oral Oncol Rep"},{"key":"3141_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2022.11.005","volume":"115","author":"Y Lu","year":"2023","unstructured":"Lu Y, Jin Z, Hou J, Wu X, Yu Z, Yao L, et al. Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer. Matrix Biol. 2023;115:1\u201315.","journal-title":"Matrix Biol"},{"key":"3141_CR24","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.7150\/jca.39723","volume":"11","author":"X Qiu","year":"2020","unstructured":"Qiu X, Cheng S-H, Xu F, Yin J-W, Wang L-Y, Zhang X-Y. Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer. J Cancer. 2020;11:2348\u201359.","journal-title":"J Cancer"},{"key":"3141_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","volume":"502","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC, San Martin A. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133\u201342.","journal-title":"Cancer Lett"},{"key":"3141_CR26","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.3390\/cancers12113244","volume":"12","author":"R P\u00e9rez-Tom\u00e1s","year":"2020","unstructured":"P\u00e9rez-Tom\u00e1s R, P\u00e9rez-Guill\u00e9n I. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers. 2020;12:3244.","journal-title":"Cancers"},{"key":"3141_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03918-w","volume":"21","author":"X Gao","year":"2023","unstructured":"Gao X, Zhou S, Qin Z, Li D, Zhu Y, Ma D. Upregulation of HMGB1 in tumor-associated macrophages induced by tumor cell-derived lactate further promotes colorectal cancer progression. J Transl Med. 2023;21:53.","journal-title":"J Transl Med"},{"key":"3141_CR28","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","volume":"39","author":"TP Brown","year":"2020","unstructured":"Brown TP, Bhattacharjee P, Ramachandran S, Sivaprakasam S, Ristic B, Sikder MOF, et al. The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment. Oncogene. 2020;39:3292\u2013304.","journal-title":"Oncogene"},{"key":"3141_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7150\/thno.20356","volume":"8","author":"J Zeng","year":"2018","unstructured":"Zeng J, Liu W, Fan YZ, He DL, Li L. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1\/AMPK-mediated autophagy. Theranostics. 2018;8:109\u201323.","journal-title":"Theranostics"},{"key":"3141_CR30","doi-asserted-by":"publisher","first-page":"gmr.15017321.","DOI":"10.4238\/gmr.15017321","volume":"15","author":"TD Han","year":"2016","unstructured":"Han TD, Shang DH, Tian Y. Docetaxel enhances apoptosis and G2\/M cell cycle arrest by suppressing mitogen-activated protein kinase signaling in human renal clear cell carcinoma. Genet Mol Res. 2016;15:gmr.15017321.","journal-title":"Genet Mol Res"},{"key":"3141_CR31","doi-asserted-by":"crossref","unstructured":"Lu Z, Zheng X, Shi M, Yin Y, Liang Y, Zou Z, et al. Lactylation: The emerging frontier in post-translational modification. Front Genet. 2024;15:1423213.","DOI":"10.3389\/fgene.2024.1423213"},{"key":"3141_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211221","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Huang H, Zhao Y. Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation. Front Immunol. 2023;14:1211221.","journal-title":"Front Immunol"},{"key":"3141_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, et al. Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22:85.","journal-title":"Genome Biol"},{"key":"3141_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41420-024-01898-4","volume":"10","author":"S Wei","year":"2024","unstructured":"Wei S, Zhang J, Zhao R, Shi R, An L, Yu Z, et al. Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K\/AKT\/HIF-1\u03b1 signal pathway in endometrial carcinoma. Cell Death Discov. 2024;10:121.","journal-title":"Cell Death Discov"},{"key":"3141_CR35","first-page":"839","volume":"12","author":"I Espinoza","year":"2022","unstructured":"Espinoza I, Kurapaty C, Park CH, Vander Steen T, Kleer CG, Wiley E, et al. Depletion of CCN1\/CYR61 reduces triple-negative\/basal-like breast cancer aggressiveness. Am J Cancer Res. 2022;12:839\u201351.","journal-title":"Am J Cancer Res"},{"key":"3141_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395047","volume":"15","author":"M-Y Xu","year":"2024","unstructured":"Xu M-Y, Xia Z-Y, Sun J-X, Liu C-Q, An Y, Xu J-Z, et al. A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance. Front Immunol. 2024;15:1395047.","journal-title":"Front Immunol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03141-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03141-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03141-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:58:53Z","timestamp":1780048733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03141-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3141"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03141-8","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Sichuan Provincial People\u2019s Hospital (Approval No.2023-580). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants gave a written informed consent for participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent for study participation"}}],"article-number":"259"}}